Fundraising FoxImbruvica
1 known investors
Find your way into Imbruvica
Sign up to find every way you can get introduced to Imbruvica
- Your email: who you already know at Imbruvica, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Imbruvica team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
IMBRUVICA is a prescription cancer medication (available as capsules, tablets, and oral suspension) used to treat B-cell malignancies such as CLL/SLL and Waldenström's macroglobulinemia, as well as chronic graft-versus-host disease in adults and children. It is marketed by AbbVie, and the page provides patient dosing instructions, safety warnings, and side-effect information.
Investors · 1
Frequently asked questions
- What does Imbruvica do?
- IMBRUVICA is a prescription cancer medication (available as capsules, tablets, and oral suspension) used to treat B-cell malignancies such as CLL/SLL and Waldenström's macroglobulinemia, as well as chronic graft-versus-host disease in adults and children. It is marketed by AbbVie, and the page provides patient dosing instructions, safety warnings, and side-effect information.
- Who are Imbruvica's investors?
- Imbruvica's investors include Aisling Capital.